News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,011 Results
Type
Article (8016)
Company Profile (141)
Press Release (477853)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166742)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8573)
News (238196)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33156)
ALS (108)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (284)
Approvals (10409)
Artificial intelligence (333)
ASCO (159)
Autoimmune disease (220)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6959)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (1)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (519)
Cancer (3759)
Cardiovascular disease (226)
Career advice (245)
Career pathing (1)
CAR-T (178)
CDC (1)
CDMO (15)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (35)
Clinical research (48040)
Collaboration (1279)
Commercialization (3)
Compensation (1533)
Complete response letters (34)
COVID-19 (762)
CRISPR (64)
C-suite (802)
Cystic fibrosis (87)
Data (5847)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (354)
Diagnostics (4218)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73748)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88108)
Executive appointments (713)
FDA (12491)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (945)
Gene editing (126)
Generative AI (11)
Gene therapy (333)
GLP-1 (294)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9367)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (106)
Immuno-oncology (61)
Indications (162)
Infectious disease (954)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (261)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (18)
Liver cancer (45)
Longevity (19)
Lung cancer (542)
Lymphoma (257)
Machine learning (29)
Management (3)
Manufacturing (565)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8678)
Medtech (8837)
Mergers & acquisitions (14409)
Metabolic disorders (726)
mRNA (62)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (227)
Neuropsychiatric disorders (40)
Neuroscience (1869)
NextGen: Class of 2026 (3151)
Non-profit (843)
Obesity (231)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (206)
Partnered (12)
Patents (497)
Patient recruitment (530)
Patient selection (2)
Peanut (32)
People (41355)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15518)
Phase 2 (21453)
Phase 3 (14464)
Pipeline (7687)
Policy (18)
Postmarket research (1570)
Preclinical (6553)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (588)
Real estate (3023)
Recruiting (6)
Regenerative medicine (2)
Regulatory (14956)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (163)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (334)
Venture capital (17)
Weight loss (75)
Women's health (88)
Date
Last 7 days (284)
Last 30 days (1338)
Last 365 days (19009)
2026 (13618)
2025 (19238)
2024 (22986)
2023 (26529)
2022 (34590)
2021 (37170)
2020 (33476)
2019 (23245)
2018 (17461)
2017 (18769)
2016 (17917)
2015 (24247)
2014 (21679)
2013 (18127)
2012 (20221)
2011 (20426)
2010 (20332)
Location
Africa (227)
Alabama (77)
Alaska (2)
Arizona (310)
Arkansas (10)
Asia (17932)
Australia (2091)
California (12344)
Canada (3236)
China (544)
Colorado (496)
Connecticut (427)
Delaware (214)
Europe (24627)
Florida (1854)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (726)
India (51)
Indiana (323)
Iowa (16)
Japan (423)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1231)
Massachusetts (8100)
Michigan (314)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2691)
New Mexico (12)
New York (2896)
North Carolina (1316)
North Dakota (4)
Northern California (6208)
Ohio (293)
Oklahoma (14)
Oregon (16)
Pennsylvania (2295)
Puerto Rico (21)
Rhode Island (30)
South America (402)
South Carolina (78)
South Dakota (1)
Southern California (5138)
Tennessee (125)
Texas (2004)
United States (40014)
Utah (372)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
486,011 Results for "medela inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Medela Expands Negative Pressure Wound Therapy Product Solutions with New Integrated Dressing
Medela, the healthcare choice for more than six million hospitals around the world*, announced today that it will introduce a new innovative sterile dressing within its negative pressure wound therapy (NPWT) portfolio in September.
August 15, 2023
·
4 min read
BioMidwest
Medela Awarded Suction Canisters Yankauers Agreement with Premier Inc.
Medela has been awarded a group purchasing agreement for Suction Canisters Yankauers with Premier Inc. Effective August 1, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for airway suction device and virus filters.
August 25, 2020
·
2 min read
BioMidwest
New Data Demonstrates Medela Innovates the Standard of Care for Negative Pressure Wound Therapy (NPWT)
Medela LLC announced the release of new data in a peer-reviewed SAWC Fall published poster and white paper supplement to Wounds demonstrating the Medela Invia Liberty Negative Pressure Wound Therapy (NPWT) System innovates the current NPWT standard of care
November 10, 2020
·
4 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
Business
Medela Awarded Lactation Care Contract from Vizient
Designation Recognizes Medela’s Commitment to Supporting Every Moms’ Breastfeeding Journey
March 19, 2019
·
2 min read
BioMidwest
Medela Awarded 2020 Vendor of the Year by the Pacific Coast Region of the Wound, Ostomy, and Continence Nurses Society™ (WOCN®)
Medela’s Healthcare business receives prestigious recognition for its ongoing efforts to support WOC Nurses across the country
July 9, 2020
·
2 min read
BioMidwest
Medela Joins the United Nations Global Compact & Launches Global Corporate Social Responsibility Program, Providing Support for COVID-19 Essential Workers
Medela Cares will donate to U.S.-based organizations supporting Black communities and essential workers during the COVID-19 crisis
August 4, 2020
·
4 min read
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
1 of 48,602
Next
